Home/Filings/4/0001209191-23-024010
4//SEC Filing

Kwan Rudolf 4

Accession 0001209191-23-024010

CIK 0001300699other

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 4:33 PM ET

Size

20.2 KB

Accession

0001209191-23-024010

Insider Transaction Report

Form 4
Period: 2023-04-07
Kwan Rudolf
EVP, Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-04-07$1.22/sh+4,017$4,90142,458 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $220.00From: 2020-06-13Exp: 2027-06-13Common Stock (7,000 underlying)
    7,000
  • Stock Option (Right to Buy)

    Exercise: $249.00Exp: 2030-06-05Common Stock (7,000 underlying)
    7,000
  • Stock Option (Right to Buy)

    Exercise: $13.31Exp: 2032-07-20Common Stock (3,750 underlying)
    3,750
  • Stock Option (Right to Buy)

    Exercise: $91.00From: 2017-06-12Exp: 2024-06-12Common Stock (2,400 underlying)
    2,400
  • Stock Option (Right to Buy)

    Exercise: $150.00From: 2019-05-22Exp: 2025-05-22Common Stock (6,000 underlying)
    6,000
  • Stock Option (Right to Buy)

    Exercise: $263.40From: 2023-02-28Exp: 2029-02-28Common Stock (6,000 underlying)
    6,000
  • Stock Option (Right to Buy)

    Exercise: $76.00Exp: 2031-08-03Common Stock (3,500 underlying)
    3,500
  • Restricted Stock Units

    Common Stock (2,625 underlying)
    2,625
  • Stock Option (Right to Buy)

    Exercise: $110.00From: 2018-12-16Exp: 2024-12-16Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $91.00From: 2018-05-13Exp: 2023-05-13Common Stock (2,400 underlying)
    2,400
  • Stock Option (Right to Buy)

    Exercise: $91.00From: 2018-02-12Exp: 2024-02-12Common Stock (6,000 underlying)
    6,000
  • Stock Option (Right to Buy)

    Exercise: $346.00From: 2022-03-27Exp: 2028-03-27Common Stock (6,000 underlying)
    6,000
Footnotes (6)
  • [F1]Shares purchased from the Issuer under a Salary Deduction and Stock Purchase Agreement at the Nasdaq Official Closing Price on the date of purchase.
  • [F2]This option vests in four equal annual installments beginning on June 5, 2021.
  • [F3]The option vests in four equal annual installments beginning on August 3, 2022.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of stock.
  • [F5]The restricted stock units vest in four equal annual installments beginning on August 3, 2022.
  • [F6]This option vests in four equal annual installments beginning on July 20, 2023.

Issuer

Athenex, Inc.

CIK 0001300699

Entity typeother

Related Parties

1
  • filerCIK 0001708965

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:33 PM ET
Size
20.2 KB